Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA plaque subcommittee meeting

This article was originally published in The Tan Sheet

Executive Summary

Dental Products Panel's Plaque Subcommittee to meet Dec. 5-7, FDA announces in Nov. 16 Federal Register. On Dec. 6, the subcommittee will meet jointly with the agency's Dental Products Panel. Discussion on all three days will focus on: the possible relationship of alcohol-containing mouthwashes to oral and pharyngeal cancers; the drug/cosmetic status of antiplaque products and claims; and general guidelines for determining the safety and effectiveness of antiplaque products. The joint meeting will also address definitions and general information related to antiplaque products and claims. A draft version of the advanced notice of proposed rulemaking on antiplaque products developed by the subcommittee will be presented at the joint session. The meeting begins at 9 a.m. each day at the Renaissance Hotel at Techworld in Washington, D.C
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS083450

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel